133 related articles for article (PubMed ID: 7681997)
21. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
22. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
23. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
24. [CNS metastases in malignant melanomas].
Willner J; Bohndorf W
Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
[TBL] [Abstract][Full Text] [Related]
25. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
26. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
27. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
28. Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis.
Buecker R; Hong ZY; Liu XM; Jaenke G; Lu P; Schaefer U
Radiat Oncol; 2019 Mar; 14(1):41. PubMed ID: 30866972
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. In regard to Graham et al. (Int J Radiat Oncol Biol Phys 2010;77(3):648-54.).
Davey P; Smith J; Ennis M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605-6; author reply 1606. PubMed ID: 21092835
[No Abstract] [Full Text] [Related]
30. Whole brain radiotherapy for the treatment of multiple brain metastases.
Tsao MN; Lloyd N; Wong R; Chow E; Rakovitch E; Laperriere N
Cochrane Database Syst Rev; 2006 Jul; (3):CD003869. PubMed ID: 16856022
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
32. Palliative whole-brain radiotherapy fractionation: convenience versus cognition?
Lutz S
Cancer; 2007 Dec; 110(11):2363-5. PubMed ID: 17893908
[No Abstract] [Full Text] [Related]
33. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
[TBL] [Abstract][Full Text] [Related]
34. [Brain metastases of bronchial and breast carcinoma. Differences in metastatic behavior and prognosis].
Nieder C; Niewald M; Hagen T
Radiologe; 1995 Nov; 35(11):816-21. PubMed ID: 8657883
[TBL] [Abstract][Full Text] [Related]
35. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapeutic treatment approaches for brain metastases.
De Felice F; Musio D; Cassese R; Tombolini V
Anticancer Res; 2014 Dec; 34(12):6913-8. PubMed ID: 25503116
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases.
Giubilei C; Ingrosso G; D'Andrea M; Benassi M; Santoni R
J Neurooncol; 2009 Jan; 91(2):207-12. PubMed ID: 18807149
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
Rades D; Haatanen T; Schild SE; Dunst J
Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
[TBL] [Abstract][Full Text] [Related]
39. [Radiation therapy for brain metastases from lung carcinoma: the second prospective randomized trial].
Chatani M; Matayoshi Y; Masaki N; Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1380-7. PubMed ID: 7596767
[TBL] [Abstract][Full Text] [Related]
40. Two new prognostic indices for brain metastases--where do we go from here?
Nieder C
Strahlenther Onkol; 2008 Sep; 184(9):488-9. PubMed ID: 19016029
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
